First Trust Small Cap Core AlphaDEX Fund
FYX - ETF AI Analysis
Top Page
First Trust Small Cap Core AlphaDEX Fund (FYX)
FYX, the First Trust Small Cap Core AlphaDEX Fund, has a solid overall rating that reflects a mix of strong standouts and more challenged holdings among small-cap stocks. Strong contributors like Academy Sports and Outdoors, with its attractive valuation, solid financial performance, and supportive technical trends, help lift the fund’s quality, while names such as Sunrun and Xeris Pharmaceuticals, which face high leverage and profitability issues, weigh on the rating. The main risk is the fund’s exposure to smaller companies that often carry higher financial and operational uncertainty, which can make performance more volatile.
FYX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.36B
- Region
- North America
- Expense Ratio
- 0.58%
- Beta
- 0.94
- Issuer
- First Trust
- Inception Date
- May 08, 2007
- Dividend Yield
- 1.11%
- Asset Class
- Equity
- Index Tracked
- Nasdaq AlphaDEX Small Cap Core Index
FYX Summary
FYX is an exchange-traded fund that follows the Nasdaq AlphaDEX Small Cap Core Index, focusing on smaller U.S. companies with room to grow. It spreads your money across many industries, including financials, health care, technology, and consumer companies. Well-known names in the fund include Kohl’s and Harley-Davidson, along with other emerging businesses. Someone might invest in FYX to diversify beyond large, well-known stocks and tap into the growth potential of smaller companies. A key risk is that small-cap stocks can be more volatile, so the fund’s value can move up and down more sharply with the market.
How much will it cost me?
FYX has an annual expense ratio of 0.58%, which means you’ll pay about $5.80 per year for every $1,000 invested. This cost is higher than the average ETF because FYX is more actively managed, using the AlphaDEX strategy to select and weight stocks rather than simply tracking a basic market index.
What would affect this ETF?
FYX could benefit if the U.S. economy stays healthy, consumer spending remains strong, and technology and health care innovation continue, supporting many of its small-cap holdings like DXC Technology, Appian, and Mattel. On the downside, rising interest rates, tighter credit conditions, or an economic slowdown would likely hurt small U.S. companies in cyclical areas such as financials, consumer discretionary, and real estate, making this ETF more volatile and sensitive to market stress.
FYX Top 10 Holdings
FYX is powered by a mix of scrappy U.S. small caps, with rising tech names like Appian and Amplitude helping to set the pace as they lean into cloud and AI themes. Retail players such as Kohl’s and Academy Sports are steady contributors, benefiting from solid cash flow even as consumer spending remains choppy. On the flip side, Comstock Resources and Mattel are lagging, with energy and toy demand losing some steam and weighing on results. Overall, the fund is broadly diversified across sectors, but leans into small-cap tech, consumer, and financial stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Xeris Pharmaceuticals | 0.49% | $6.71M | $2.78B | 97.15% | 46Neutral | |
| Appian | 0.45% | $6.17M | $3.70B | 34.52% | 58Neutral | |
| Stagwell | 0.44% | $6.03M | $2.89B | 107.12% | 65Neutral | |
| Academy Sports and Outdoors | 0.43% | $5.90M | $4.14B | 46.07% | 75Outperform | |
| DXC Technology | 0.43% | $5.79M | $2.31B | 8.94% | 62Neutral | |
| Ardent Health Partners, Inc. | 0.42% | $5.65M | $2.44B | 19.64% | 68Neutral | |
| Harley-Davidson | 0.42% | $5.64M | $3.30B | 29.91% | 60Neutral | |
| First Advantage | 0.41% | $5.58M | $4.05B | 70.51% | 51Neutral | |
| Sunrun | 0.40% | $5.42M | $2.41B | -51.13% | 52Neutral | |
| Septerna, Inc. | 0.39% | $5.27M | $2.28B | 159.84% | 61Neutral |
FYX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FYX, the sentiment is Negative. The current price of 136.73 is below the 20-day moving average (MA) of 137.25, below the 50-day MA of 137.64, and above the 200-day MA of 132.75, indicating a neutral trend. The MACD of 0.40 indicates Negative momentum. The RSI at 47.13 is Neutral, neither overbought nor oversold. The STOCH value of 38.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FYX.
FYX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $136.73 | $147.00(7.51% Upside) | $1.36B | 0.58% | 65Neutral | |
| $35.48 | $42.07(18.58% Upside) | $8.78B | 0.25% | 67Neutral | |
| $44.33 | $57.52(29.75% Upside) | $6.61B | 0.28% | 64Neutral | |
| $128.08 | $155.68(21.55% Upside) | $4.07B | 0.07% | 66Neutral | |
| $83.45 | $103.14(23.59% Upside) | $4.13B | 0.15% | 66Neutral | |
| $56.76 | $64.70(13.99% Upside) | $3.85B | 0.59% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FYX | First Trust Small Cap Core AlphaDEX Fund | 136.73 | 28.39 | 26.21% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 35.48 | 4.86 | 15.87% | |
| FESM | Fidelity Enhanced Small Cap ETF | 44.33 | 7.39 | 20.00% | |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 128.08 | 18.38 | 16.75% | |
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | 83.45 | 9.62 | 13.03% | |
| CALF | Pacer US Small Cap Cash Cows 100 ETF | 56.76 | 13.32 | 30.68% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
